Back to top
more

Sotera Health (SHC)

(Delayed Data from NSDQ)

$11.27 USD

11.27
1,100,711

+0.07 (0.63%)

Updated May 1, 2024 04:00 PM ET

After-Market: $11.26 -0.01 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Sotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth

Sotera Health (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sotera Health Company (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Sotera Health Company (SHC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sotera Health Company (SHC) Meets Q4 Earnings Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 0% and 3.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Unveiling Sotera Health Company (SHC) Q4 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Sotera Health Company (SHC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Teladoc (TDOC) Reports Q4 Loss, Misses Revenue Estimates

Teladoc (TDOC) delivered earnings and revenue surprises of 22.73% and 1.53%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Earnings Expected to Grow: Should You Buy?

Sotera Health Company (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMN Healthcare Services (AMN) Q4 Earnings and Revenues Surpass Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.76% and 1.89%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, Sotera Health Company (SHC) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Sotera Health Company (SHC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sotera Health Company (SHC) Tops Q2 Earnings Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 16.67% and 2.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Sotera Health Company (SHC): Can Its 17.3% Jump Turn into More Strength?

Sotera Health Company (SHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Sotera Health Company (SHC) Q1 Earnings and Revenues Lag Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of -7.14% and 0.05%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Life Time Group Holdings, Inc. (LTH) Surpasses Q1 Earnings and Revenue Estimates

Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of 42.86% and 0.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Beats Q4 Earnings and Revenue Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 13.64% and 1.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ModivCare (MODV) Q4 Earnings and Revenues Surpass Estimates

ModivCare (MODV) delivered earnings and revenue surprises of 35.26% and 6.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Q3 Earnings and Revenues Surpass Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 4.55% and 1.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Tops Q2 Earnings and Revenue Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 12.50% and 3.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Stock Jumps 6.5%: Will It Continue to Soar?

Sotera Health Company (SHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Sotera Health Company (SHC) Q1 Earnings and Revenues Surpass Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 15.79% and 2.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Why Sotera Health Company (SHC) is Poised to Beat Earnings Estimates Again

Sotera Health Company (SHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates

Charles River (CRL) delivered earnings and revenue surprises of 1.48% and 0.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Earnings Expected to Grow: Should You Buy?

Sotera Health Company (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.